Cleared Traditional

K223575 - Phoenix ICON, Phoenix ICON GO (FDA 510(k) Clearance)

Class II Ophthalmic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K223575 · Neolight, LLC · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
280d
Days
Class 2
Risk

K223575 is an FDA 510(k) clearance for the Phoenix ICON, Phoenix ICON GO. Classified as Camera, Ophthalmic, Ac-powered (product code HKI), Class II - Special Controls.

Submitted by Neolight, LLC (Pleasanton, US). The FDA issued a Cleared decision on September 6, 2023 after a review of 280 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1120 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Neolight, LLC devices

Submission Details

510(k) Number K223575 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 30, 2022
Decision Date September 06, 2023
Days to Decision 280 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
170d slower than avg
Panel avg: 110d · This submission: 280d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HKI Camera, Ophthalmic, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HKI Camera, Ophthalmic, Ac-powered

All 155
Devices cleared under the same product code (HKI) and FDA review panel - the closest regulatory comparables to K223575.
Eyer 2
K251353 · Phelcom Technologies · Jan 2026
Fundus On Phone Non Mydriatic (FOP NM-10)
K252120 · Remidio Innovative Solutions Private Limited · Dec 2025
Optina-4C (MHRC-C1N)
K250770 · Optina Diagnostics, Inc. · Sep 2025
3nethra neo HD FA
K243600 · Forus Health Pvt.Ltd · Aug 2025
Resolve Fundus Camera
K250683 · Optain Health, Inc. · Apr 2025
Sentinel Camera
K243664 · Ai Optics · Dec 2024